SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000905718-21-001619
Filing Date
2021-12-17
Accepted
2021-12-17 16:31:40
Documents
1
Period of Report
2021-10-06

Document Format Files

Seq Description Document Type Size
1 effector_fm4oct062021.html 4/A  
1 effector_fm4oct062021.xml 4/A 5638
  Complete submission text file 0000905718-21-001619.txt   7112
Mailing Address C/O AILERON THERAPEUTICS, INC. 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address
Gallagher Brian M. Jr. (Reporting) CIK: 0001709976 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39866 | Film No.: 211502007

Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations